Stifel Downgrades Canoo to Hold Amid Capital Challenges
Stifel has downgraded Canoo to Hold, setting a 50-cent price target due to the company's capital needs and production suspension. Learn more about Canoo's financial outlook.
Topic
Downgrade
A collection of 23 issues
JPMorgan Downgrades Anadolu Efes's 2028 Bonds
JPMorgan has downgraded Anadolu Efes's 2028 dollar bonds to underweight, highlighting risks on earnings due to potential permanent Russian management change.
Rodman & Renshaw Downgrades Viracta Therapeutics
Rodman & Renshaw downgrade Viracta Therapeutics to Neutral, slashing price target from $3.50 to 25c. Key implications for healthcare and clinical trials.